TRIPP Act

The TRIPP Act requires the U.S. President to oppose any waiver of World Trade Organization (WTO) members' obligations under global intellectual property rules (the TRIPS Agreement) unless Congress passes a new law explicitly authorizing such a waiver. This bill directly affects U.S. trade policy decisions and WTO negotiations, particularly regarding access to medicines or other intellectual property during crises. The key mechanism is a binding presidential obligation to resist waivers without specific congressional approval, reinforcing existing intellectual property protections in international trade agreements.